• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH CALCIUM; AZO DYE, CALCIUM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH CALCIUM; AZO DYE, CALCIUM Back to Search Results
Catalog Number 03L79-22
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/26/2024
Event Type  malfunction  
Manufacturer Narrative
A1 patient identifier: complete sample id is (b)(6) an evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer reported falsely elevated calcium generated from an architect c8000 and provided the following data for 1 patient: customer reference range ¿ normal is up to 2.55 mmol/l sample id (b)(6)initial result was 3.547, repeat results were 2.526; 2.497; 2.494; 2.506; 2.504; 2.503; 2.492; 2.487; 2.495: 2.493: 2.499.Per the customer the discrepant result(s) were not reported out of the laboratory.There was no reported impact to patient management.
 
Event Description
The customer reported falsely elevated calcium generated from an architect c8000 and provided the following data for 1 patient: customer reference range ¿ normal is up to 2.55 mmol/l sample id (b)(6) initial result was 3.547, repeat results were 2.526; 2.497; 2.494; 2.506; 2.504; 2.503; 2.492; 2.487; 2.495: 2.493: 2.499.Per the customer the discrepant result(s) were not reported out of the laboratory.There was no reported impact to patient management.
 
Manufacturer Narrative
The complaint investigation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, and device history record review.Return testing was not completed as returns were not yet available.Data and information provided by the customer were reviewed and support the complaint issue without indication for any additional issue.Device history review did not identify any associated non-conformances or deviations related to the customer issue with the complaint lot.Ticket search by lot did not identify an increase in complaint activity for the complaint lot.Trending review has not identified any trends.Labeling was reviewed and was found to address the customer reported issue.Based on the available information, no systemic issue or deficiency was identified for the calcium reagent lot 72897un23.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CALCIUM
Type of Device
AZO DYE, CALCIUM
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key18840832
MDR Text Key336957532
Report Number3002809144-2024-00060
Device Sequence Number1
Product Code CJY
UDI-Device Identifier00380740161491
UDI-Public00380740161491
Combination Product (y/n)N
Reporter Country CodeRS
PMA/PMN Number
K062855
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/05/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number03L79-22
Device Lot Number72897UN23
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/26/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC C8 PROC MOD, 01G06-11, (B)(6). ; ARC C8 PROC MOD, 01G06-11, (B)(6).
-
-